Pressure Builds For Biosimilars To Follow Lilly’s Lead After Insulin Price Cap
Eli Lilly Will Bear The Cost Of A $35 Price Cap On All Copays For Its Insulins
Lilly insulin users will be able to receive their medicine for $35 a month • Source: Shutterstock 
